(Q36031960)

11 August 2017

title

Single dose safety, tolerance, and pharmacokinetics of HP 029 in healthy young men: a potential Alzheimer agent (English)

1 reference

11 August 2017

0 references

1 reference

Puri SK

1

1 reference

11 August 2017

Hsu RS

series ordinal

2

1 reference

11 August 2017

Ho I

series ordinal

3

1 reference

11 August 2017

Lassman HB

series ordinal

4

1 reference

11 August 2017

publication date

1 March 1989

1 reference

The Journal of Clinical Pharmacology

11 August 2017

published in

1 reference

11 August 2017

volume

29

1 reference

11 August 2017

issue

3

1 reference

11 August 2017

page(s)

278-284

1 reference

Selective loss of central cholinergic neurons in Alzheimer's disease

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1989.TB03328.X

Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1989.TB03328.X

Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1989.TB03328.X

Enhancement of memory processes in Alzheimer's disease with multiple-dose intravenous physostigmine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1989.TB03328.X

Physostigmine effects in Alzheimer's disease: relationship to dementia severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1989.TB03328.X

Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1989.TB03328.X

Preliminary Report: Intracranial Cholinergic Drug Infusion in Patients with Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1989.TB03328.X

(+/-)-9-Amino-1,2,3,4-tetrahydroacridin-1-ol. A potential Alzheimer's disease therapeutic of low toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1989.TB03328.X

Isolation and the fluorometric, high-performance liquid chromatographic determination of tacrine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1989.TB03328.X

Oral physostigmine treatment of patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1989.TB03328.X

10.1002/J.1552-4604.1989.TB03328.X

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference